PEXIDARTINIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 39 adverse event reports in the FDA FAERS database where PEXIDARTINIB was used for Neoplasm.
Most Reported Side Effects for PEXIDARTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 378 | 39.0% | 3 | 38 |
| Product dose omission issue | 335 | 34.5% | 3 | 30 |
| Hair colour changes | 327 | 33.7% | 1 | 27 |
| Nausea | 213 | 22.0% | 2 | 25 |
| Pruritus | 186 | 19.2% | 0 | 10 |
| Aspartate aminotransferase increased | 134 | 13.8% | 3 | 21 |
| Rash | 131 | 13.5% | 2 | 12 |
| Off label use | 130 | 13.4% | 6 | 16 |
| Alanine aminotransferase increased | 124 | 12.8% | 1 | 20 |
| Diarrhoea | 106 | 10.9% | 3 | 12 |
| Headache | 103 | 10.6% | 0 | 11 |
| Pain | 100 | 10.3% | 1 | 15 |
| Arthralgia | 94 | 9.7% | 0 | 13 |
| Therapy cessation | 94 | 9.7% | 2 | 6 |
| Product dose omission in error | 86 | 8.9% | 0 | 7 |
Other Indications for PEXIDARTINIB
Giant cell tumour of tendon sheath (393)
Synovitis (306)
Connective tissue neoplasm (240)
Soft tissue neoplasm (223)
Product used for unknown indication (114)
Malignant connective tissue neoplasm (19)
Neoplasm skin (18)
Soft tissue sarcoma (17)
Neoplasm malignant (8)
Bone neoplasm (7)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)